NEOVAXSYN INC
AMES, United States · Founded 2020 · $300K raised
- Headquarters
- AMES, Iowa
- Employees
- 1–10
- Founded
- 2020
- Business Model
- B2G
- Total Funding
- $300K
- Last Round
- $300K GrantJan 2023
- Rounds
- 1
About
NeoVaxSyn, Inc. is a Salt Lake City-based vaccine R&D company developing novel immunogens designed to induce broadly protective neutralizing antibodies against viruses including HIV-1, influenza, and SARS-CoV-2. The company focuses on engineering vaccine candidates that target critical epitopes on viral surface antigens to enable stronger immune responses. Funded through NIH SBIR/STTR awards from the Department of Health and Human Services.
Summary
NEOVAXSYN INC is a Biotech company based in AMES, United States, founded in 2020. It has raised $300K in total across 1 round, most recently a $300K Grant round in Jan 2023. Investors include National Institute of Allergy and Infectious Diseases.
Funding History
Jan 2023
Investors
Similar Companies
China's leading blood products manufacturer
IVI-RMA provides fertility treatments and patient-centered reproductive care, combining research,...
Altos Labs combines academic science and industry development to create medicines that restore ce...
inVentiv Health merged with INC Research to form Syneos Health, integrating clinical and commerci...
Specialty pharmaceutical company
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/neovaxsyn-inc"><img src="https://indexed.vc/api/badge/company/neovaxsyn-inc" alt="NEOVAXSYN INC on Indexed.vc" width="260" height="76" /></a>